Author/Authors :
Dawe, David E. Department of Hematology and Medical Oncology Cancer Care Manitoba, Winnipeg, Canada , Singh, Harminder Department of Hematology and Medical Oncology Cancer Care Manitoba, Winnipeg, Canada , Wickramasinghe, Lahiru Department of Community Health Sciences - Faculty of Health Sciences - University of Manitoba, Winnipeg, Canada , Pitz, Marshall W. Department of Hematology and Medical Oncology Cancer Care Manitoba, Winnipeg, Canada , Torabi, Mahmoud Department of Community Health Sciences - Faculty of Health Sciences - University of Manitoba, Winnipeg, Canada
Abstract :
Background. Screening decreases non-small cell lung cancer (NSCLC) deaths and is recommended by the Canadian Task Force
on Preventive Health Care.We investigated risk factor prevalence and NSCLC incidence at a small region level to inform resource
allocation for lung cancer screening. Methods. NSCLC diagnoses were obtained fromthe Canadian Cancer Registry, then geocoded
to 283 small geographic areas (SGAs) in Manitoba. Sociodemographic characteristics of SGAs were obtained from the 2006
Canadian Census and Canadian Community Health Survey. Geographical variation was modelled using a Bayesian spatial Poisson
model. Results. NSCLC incidence in SGAs ranged from 1 to 343 cases per 100,000 population per year. The highest incidence rates
were in the Southeastern, Southwestern, and Central regions of Manitoba, while most of Northern Manitoba had lower rates.
Poisson regression suggested areas with higher proportions of Aboriginal people and higher average income, and immigrants had
lower NSCLC incidence whereas areas with higher proportions of smokers had higher incidence. Conclusion. On an SGA level,
smoking rates remain themost significant factor driving NSCLCincidence. Socioeconomic status and proportions of immigrants or
Aboriginal peoples independently impact NSCLC rates.We have identified SGAs inManitoba to target in policy and infrastructure
planning for lung cancer screening.
Keywords :
Geographical Variation , Non-Small Cell , Lung Cancer , Manitoba